Abstract

Objectives Epidermal growth factor receptor pathway substrate 8 (EPS8) is a scaffolding protein involved in regulating cell proliferation, actin dynamics, and receptor trafficking in human cells. EPS8 expression is increased in a range of human cancers, including head and neck squamous cell carcinoma (HNSCC). Previous studies have indicated that overexpression of EPS8 enhances mitogenesis and migration of tumor cells and is sufficient to convert nontumorigenic cells to a tumorigenic phenotype. The nonreceptor tyrosine kinase Src is reported to phosphorylate EPS8 at 4 tyrosine residues, although the impact of this on EPS8 function is unknown. The purpose of this study was to investigate the role of tyrosine phosphorylation of EPS8 at Src target sites in modulating biochemical functions, cell growth, and motility in HNSCC. Study Design Expression plasmids encoding EPS8 with amino acid substitutions to phenylalanine (F) at the 4 putative Src phosphorylation sites (Y485 F, Y525 F, Y602 F, Y774 F), and all 4 combined (4 F), were prepared by site-directed mutagenesis. To evaluate the effect of unphosphorylated EPS8 on downstream signals and biologic behavior, plasmids were transduced into a model cell line expressing a normal endogenous level of EPS8. Additionally, cells were treated with dasatinib, a Src inhibitor, to block phosphorylation of Src substrates. Expression of downstream targets was evaluated by Western blotting. Wound closure and proliferation assays were used to investigate the impact of these mutations on cell motility and growth. Results FOXM1, AURKA, and AURKB levels were decreased in cells expressing the nonphosphorylatable 4 F and Y602 F EPS8 mutants, whereas cells harboring the Y485 F, Y525 F, and Y774 F EPS8 mutants showed no differences in the expression of these proteins compared with controls. Moreover, dasatinib treatment resulted in a significant decrease in the expression of EPS8 downstream targets. In addition, both Y602 F and 4 F mutants elicited a significant reduction in tumor cell proliferation and migration. Conclusions The nonphosphorylatable Y602 F-EPS8 and 4 F-EPS8 mutants decreased the expression of EPS8 downstream targets, as well as reducing tumor cell growth and motility, implying a crucial role for phosphorylation of EPS8, principally at Y602, in mediating protumorigenic signal transduction.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call